Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:743-749

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wada, H.
Right arrow Articles by Seishima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wada, H.
Right arrow Articles by Seishima, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Growth factors/cytokines

(Circulation. 2001;103:743.)
© 2001 American Heart Association, Inc.


Basic Science Reports

Tumor Necrosis Factor-{alpha} (TNF-{alpha}) Plays a Protective Role in Acute Viral Myocarditis in Mice

A Study Using Mice Lacking TNF-{alpha}

Hisayasu Wada, MD, PhD; Kuniaki Saito, PhD; Tsugiyasu Kanda, MD, PhD; Isao Kobayashi, MD, PhD; Hidehiko Fujii, MD, PhD; Suwako Fujigaki, BSc; Naoya Maekawa, BSc; Hisato Takatsu, MD, PhD; Hisayoshi Fujiwara, MD, PhD; Kenji Sekikawa, PhD; Mitsuru Seishima, MD, PhD

From the Department of Laboratory Medicine (H.W., K. Saito, H. Fujii, S.F., N.M., M.S.) and Second Department of Internal Medicine (H.T., H. Fujiwara), Gifu University School of Medicine, Gifu; Department of Laboratory Medicine, Gunma University School of Medicine, Gunma (T.K., I.K.); and Department of Immunology, National Institute of Animal Health (K. Sekikawa), Japan.

Correspondence to Hisayasu Wada, MD, PhD, Department of Laboratory Medicine, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu 500-8705, Japan. E-mail wadah{at}cc.gifu-u.ac.jp

Background—It has been reported that tumor necrosis factor-{alpha} (TNF-{alpha}) is expressed in the heart with viral myocarditis and that its expression aggravates the condition. The pathophysiological effects of TNF-{alpha} on viral myocarditis, however, have not been fully elucidated.

Methods and Results—To investigate the role of TNF-{alpha} in the progression of viral myocarditis, we used TNF-{alpha} gene–deficient mice (TNF-{alpha}-/-) and induced acute myocarditis by infection with encephalomyocarditis virus (EMCV). The survival rate of TNF-{alpha}-/- mice after EMCV infection was significantly lower than that of TNF-{alpha}+/+ mice (0% versus 67% on day 14). Injection of recombinant human TNF-{alpha} (0.2 to 4.0 µg/mouse IV) improved the survival of TNF-{alpha}-/- mice in a dose-dependent manner, indicating that TNF-{alpha} is essential for protection against viral myocarditis. The levels of viral titer and viral genomic RNA of EMCV in the myocardium were significantly higher in TNF-{alpha}-/- than in TNF-{alpha}+/+ mice. Histopathological examination showed that the inflammatory changes of the myocardium were less marked in TNF-{alpha}-/- than in TNF-{alpha}+/+ mice. Immunohistochemical analysis revealed that the levels of immunoreactivity of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the myocardium were decreased in TNF-{alpha}-/- mice compared with TNF-{alpha}+/+ mice.

Conclusions—These observations suggested that TNF-{alpha} is necessary for adhesion molecule expression and to recruit leukocytes to inflammatory sites, and thus, the lack of this cytokine resulted in failure of elimination of infectious agents. We concluded that TNF-{alpha} plays a protective role in the acute stage of viral myocarditis.


Key Words: tumor necrosis factor-{alpha} • myocarditis • viruses • cell adhesion molecules




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
K. A. Binymin
Comment on: Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept
Rheumatology, November 1, 2007; 46(11): 1741 - 1742.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. A. Jankowska, P. Ponikowski, M. F. Piepoli, W. Banasiak, S. D. Anker, and P. A. Poole-Wilson
Autonomic imbalance and immune activation in chronic heart failure - Pathophysiological links
Cardiovasc Res, June 1, 2006; 70(3): 434 - 445.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Li, D. Georgakopoulos, G. Lu, L. Hester, D. A. Kass, J. Hasday, and Y. Wang
p38 MAP Kinase Mediates Inflammatory Cytokine Induction in Cardiomyocytes and Extracellular Matrix Remodeling in Heart
Circulation, May 17, 2005; 111(19): 2494 - 2502.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. A. Huber and D. Sartini
Roles of Tumor Necrosis Factor Alpha (TNF-{alpha}) and the p55 TNF Receptor in CD1d Induction and Coxsackievirus B3-Induced Myocarditis
J. Virol., March 1, 2005; 79(5): 2659 - 2665.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Guilherme, P. Cury, L. M.F. Demarchi, V. Coelho, L. Abel, A. P. Lopez, S. E. Oshiro, S. Aliotti, E. Cunha-Neto, P. M.A. Pomerantzeff, et al.
Rheumatic Heart Disease: Proinflammatory Cytokines Play a Role in the Progression and Maintenance of Valvular Lesions
Am. J. Pathol., November 1, 2004; 165(5): 1583 - 1591.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. CHEN, Q. KE, Y. YANG, J. S. RANA, J. TANG, J. P. MORGAN, and Y.-F. XIAO
Cardiomyocytes overexpressing TNF-{alpha} attract migration of embryonic stem cells via activation of p38 and c-Jun amino-terminal kinase
FASEB J, December 1, 2003; 17(15): 2231 - 2239.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Martire, B. Fernandez, A. Buehler, C. Strohm, J. Schaper, R. Zimmermann, P. E Kolattukudy, and W. Schaper
Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation
Cardiovasc Res, February 1, 2003; 57(2): 523 - 534.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
P. Liu, P. Lee, K. Fuse, and M. Nian
Molecular pathophysiological mechanisms in virus infected host myocardium
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I37 - I41.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
R. M Smith, S. Lecour, and M. N Sack
Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program
Cardiovasc Res, August 15, 2002; 55(3): 474 - 482.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. M Smith, N. Suleman, J. McCarthy, and M. N Sack
Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNF{alpha} gene
Cardiovasc Res, August 15, 2002; 55(3): 553 - 560.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Knuefermann, S. Nemoto, G. Baumgarten, A. Misra, N. Sivasubramanian, B. A. Carabello, and J. G. Vallejo
Cardiac Inflammation and Innate Immunity in Septic Shock* : Is There a Role for Toll-Like Receptors?
Chest, April 1, 2002; 121(4): 1329 - 1336.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Scheubel, B. Bartling, A. Simm, R.-E. Silber, K. Drogaris, D. Darmer, and J. Holtz
Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: Fragile balance of myocyte survival?
J. Am. Coll. Cardiol., February 6, 2002; 39(3): 481 - 488.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. L. Mann
Tumor Necrosis Factor and Viral Myocarditis: The Fine Line Between Innate and Inappropriate Immune Responses in the Heart
Circulation, February 6, 2001; 103(5): 626 - 629.
[Full Text] [PDF]